Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.

Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.4.2. Removed references to Lung cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.1.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 was added, and Lung cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.0 were removed.SummaryDifference0.1%

- Check33 days agoChange DetectedUI text updates include added options to show or hide the glossary, and new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Old items such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page shows a new revision label v3.3.4 replacing v3.3.3; no substantive study information was altered.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations where the trial is conducted were updated, with additions of numerous site locations and related topics such as MedlinePlus Genetics. Several location-specific entries were removed.SummaryDifference2%

- Check70 days agoChange DetectedRemoved the related topics 'Lung cancer' and 'MedlinePlus Genetics' from the page's related topics section.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.